Stay updated on Pemetrexed Maintenance & ADXS11-001 Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Pemetrexed Maintenance & ADXS11-001 Immunotherapy Clinical Trial page.

Latest updates to the Pemetrexed Maintenance & ADXS11-001 Immunotherapy Clinical Trial page
- Check4 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check11 days agoChange DetectedA banner announces an NIH-wide transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check18 days agoChange DetectedThe site footer revision changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check46 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the expected study record with a site error message. This indicates an access restriction or server-side issue preventing viewing the record.SummaryDifference17%

- Check67 days agoChange DetectedA new revision tag 'Revision: v3.6.6' has been added, replacing the previous 'Revision: v3.6.5' tag.SummaryDifference0.1%

Stay in the know with updates to Pemetrexed Maintenance & ADXS11-001 Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pemetrexed Maintenance & ADXS11-001 Immunotherapy Clinical Trial page.